Health Condition 1: A190- Acute miliary tuberculosis of a single specified site Health Condition 2: A191- Acute miliary tuberculosis of multiple sites Health Condition 3: A192- Acute miliary tuberculosis, unspecified Health Condition 4: A171- Meningeal tuberculoma Health Condition 5: A199- Miliary tuberculosis, unspecified Health Condition 6: A198- Other miliary tuberculosis Health Condition 7: A158- Other respiratory tuberculosis Health Condition 8: A178- Other tuberculosis of nervous system He
Conditions
Interventions
None listed
Sponsors
DR TMA PAI PhD FELLOWSHIP
Eligibility
Inclusion criteria
Inclusion criteria: Tuberculosis patients who take anti-tuberculosis drugs and comedications Tuberculosis patients aged 18 and above
Exclusion criteria
Exclusion criteria: Patients with liver abnormalities based on abnormal liver function tests during admission Pregnant and lactating tuberculosis patients Mentally challenged tuberculosis patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Early identification of risk factors and prevention of drug-drug interactions in tuberculosis patients by using a developed prediction model The developed model serves as the point of care for tuberculosis patients Reduction in anti-tuberculosis drugs related liver injuryTimepoint: 24th month | — |
Secondary
| Measure | Time frame |
|---|---|
| The developed model serves as the point of care for tuberculosis patients Reduction in anti-tuberculosis drugs related liver injuryTimepoint: 30th month | — |
Countries
India
Contacts
Public ContactDr Mahadev Rao
Manipal College of Pharmaceutical Sciences
Outcome results
None listed